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The two-dimensional mapping of tryptic peptides of en~eph~omyo~arditis virus-specific proteins has 
demonstrate that the amino acid sequence of non-st~~tur~ ~l~eptide G co~titutes a portion of the 
molecule of a precursor of capsid proteins, polypeptide A. The results of pulse-chase in vitro translation 
experiments trongly suggest hat polypeptide G corresponds to a C-terminal moiety of polypeptide A. 
Variations in the polyprotein cleavage maps of different picornaviruses are briefly discussed. 
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1. INTRODUCTION 
Genomic RNA of picornaviruses has a single site 
for initiation of translation and directs the syn- 
thesis of giant poiyprotein molecules which 
undergo multiple proteolytic cleavages before be- 
ing ultimately converted into ‘mature’ virus- 
specific polypeptides. The schemes that reflect the 
precursor-product relationships of polypeptides 
formed upon the processing of the polyprotein as 
well as the order, in this polyprotein molecule, of 
the amino acid sequences corresponding to par- 
ticular polypeptides are termed polyprotein 
cleavage maps. The general outline of the cleavage 
maps of different picornavi~ses was elucidated 
about a decade ago (review [l]), and many impor- 
tant details have been learned since. The polypro- 
tein of encephalomyocarditis (EMC) virus, while 
in a nascent form, is cleaved into leader polypep- 
tides [2] and polypeptides A, F and C (in this order 
from the N-terminus) [3]. Poly~ptide A is a 
precursor of the capsid proteins, polypeptide F is 
a stable product with yet undefined functions, and 
polypeptide C is converted into a number of pro- 
teins that include participants of the viral genome 
replication as well as the viral protease [3-51. 
However, the map position of several low-MI 
polypeptides remained uncertain. Among these 
was polypeptide G, a basic RNA-binding protein 
[6,7] which was found in association with 
ribosomes of the virus-infected cells [8]. 
* TO whom reprint requests should be addressed 
Mapping polypeptide G by following the incor- 
poration of labelled amino acids into different pro- 
teins after the arrest of initiation of translation 
suggested that G should be placed somewhere bet- 
ween the capsid proteins and polypeptide F [9], 
although other possibilities were also considered 
by the same investigators [9,10]. There was a pro- 
posal that G, like A, was a product of the primary 
cleavage of the nascent polyprotein 191. In [7] we 
observed that G was produced upon the treatment 
with the viral protease of a mixture of high-MI 
polypeptides formed upon a short incubation of an 
EMC virus RNA-programmed cell-free system. 
Since these high-M; poly~ptides consisted largely 
of precursors of the capsid proteins, it might be 
suggested that a capsid protein precursor contain- 
ed the amino acid sequence of G. Such conclusion, 
however, could be challenged inasmuch as the 
substrate for protease was not precisely 
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characterized in those experiments. 
Here, we will show that all the methionine- 
containing tryptic peptides of G can be found in 
the molecule of polypeptide A, a precursor of the 
capsid proteins. Pulse-chase in vitro translation ex- 
periments suggest that G corresponds to a C- 
terminal portion of A. 
2. METHODS 
The infection of Krebs-II cells with EMC virus 
was done as in [I 11. The in vivo labelling of virus- 
specific proteins was achieved by incubation of the _. 
infected cells with [35S]methionine 
(1200 Ci/mmol; 50 &i/ml) from 3.5-4.5 h. Viral 
RNA was translated in micrococcal nuclease- 
treated extracts from uninfected Krebs-II cells [4]. 
As substrates, [3sS]methionine (50 Ci/mmol; 
lOO&i/ml) or a mixture of “C-labelled lysine, 
354 Ci/mol, leucine, 348 Ci/mol and valine, 
265 Ci/mol (Amersham), each at 5 PM, were used 
in experiments aimed at obtaining the proteins for 
fingerprinting and in kinetic studies, respectively. 
Electrophoretic separation of the virus-specific 
polypeptides was done in 12.5% or 8-2OYo gra- 
dient polyacrylamide gel slabs in the presence of 
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Fig. 1. A comparison of tryptic peptide maps of polypeptides A and G. The polypeptides were isolated ither from the 
products of cell-free synthesis (two upper photographs), or from the virus-infected cells (G in vivo) by preparative 
electrophoresis in 12.5% polyacrylamide slab gels. A map obtained upon photographic superimposition of the two 
upper maps is also given (A + G); - peptides shared by A and G. 
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SDS using a discontinuous buffer system [12]. 
Trypsinolysis and two-dimensional fingerprin- 
3. RESULTS AND DISCUSSION 
ting of 35S-labelled polypeptides were performed 
essentially as in [2]. 
The kinetics of accumulation of virus-specific 
polypeptides in vitro was investigated in pulse- 
chase experiments (see fig.3). The autoradiographs 
of the electrophoretically separated proteins were 
scanned using an Acta CIII spectrophotometer 
(Beckman). The areas under the peaks of radioac- 
tivity (expressed in arbitrary units) were divided by 
the &values of the corresponding polypeptides, 
and the values of relative radioactivity thus obtain- 
ed were plotted against the duration of the pulse 
Circumstantial evidence that the amino acid se- 
quence of polypeptide G was a part of the molecule 
of a capsid protein precursor was obtained in [7]. 
To verify this directly, fingerprints of tryptic pep- 
tides of A and G were compared. All the 
methionine-containing peptides derived from G 
(either synthesized in vitro or isolated from the 
virus-infected cells) have counterparts in the 
fingerprint of A (fig.1). Thus, it may be concluded 
that G is a product of the proteolytic cleavage of 
A. 
Other stable products formed upon processing 
with radioactive substrate. 
a bcdefg 
of A include capsid polypeptides 6, p, y and (Y [3]. 
hijklmnopq 
Fig.2. Accumulation of virus-specific polypeptides in a cell-free pulse-chase xperiment. Translation samples 
programmed with EMC virus RNA were incubated with a mixture of 14C-labelled ammo acids for (min): 5 (a), 10 (b). 
15 (c), 20 (d), 25 (e), 30 (f), 35 (g), 40 (h), 50 ci), 55 (k), 60 (l), 65 (m), 70 (n), 90 (0); cold amino acids in 200-fold 
excess as well as calf liver tRNA, 130pg/ml (Boehringer) were then added to each sample, and incubation was 
continued; the total incubation time (pulse + chase) was 2.5 h. Polypeptides from the sample incubated with labelled 
amino acids for 2.5 h are shown in lane p, and polypeptides labelled in vivo are shown in lane q. Electrophoresis was 
performed in an 8-20% gradient polyacrylamide slab gel. 
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Polypeptides S, ,# and y are known to derive from 
a common intermediate precursor, polypeptide 
Dl. To determine the position of the amino acid 
sequence of G relative to the other products of the 
processing of A, the kinetics of accumulation of 
polypeptides Dl, LY and G was studied in in vitro 
pulse-chase xperiments. In these experiments, the 
total duration of incubation (pulse with labelled 
substrate + chase with excess cold amino acids) 
was sufficiently long (2.5 h) to permit both the 
synthesis of the viral protease and the protease- 
mediated processing of A into Dl , a and G. It may 
be noted that further processing of Dl proceeded 
less efficiently in the cell-free system and therefore 
could not invalidate our conclusions. The elec- 
trophoretic patterns obtained in one of such pulse- 
chase experiments are presented in fig.2. It is seen 
that the labelled virus-specific polypeptides were 
accumulating in a certain succession, which should 
reflect the order of the corresponding amino acid 
sequences in the pol~rotein molecule. The succes- 
sion did not appear to be appreciably affected by 
the residual incorporation of the labelled amino 
acids during the chase period. (This in- 
completeness of the chase was evidenced by the 
faint bands of polypeptides C, D, E and F in 
samples that had been incubated with the radioac- 
tive substrates for only 5-10 min.) 
The kinetics of the label incorporation into Dl, 
(Y and G, calculated from fig.2 as in section 2, is 
presented in fig.3. The data clearly demonstrate 
that it was the polypeptide Dl moiety of A that 
was labelled first, then followed the synthesis of cy 
and, finally, of G. Thus, the order of these 3 
polypeptides in A should be NHz-Dl-a--G- 
COOH. This order is in line with the pre- 
determined reIative positions of DI and a and 
agrees with the proposal that G should be placed 
somewhere between u and F [3]. The data of fig.3 
also suggest that G might probably be produced, in 
our system, in a relatively lower molar concentra- 
tion compared to Dl or cy. This observation might 
be an artifact caused by some peculiarities of 
amino acid composition of the 3 polypeptides; 
alternatively, it might be explained by premature 
terminations of translation within the genome 
region encoding polypeptide A, or by multiple 
reinitiations of translation. 
We can now propose the following cleavage map 
of the N-terminal portion of the EMC virus 
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Fig.3. Kinetics of labelling of polypeptides Dl, LY and G 
in the pulse-chase experiment presented in fig.2. For the 
method of calculation of the relative radioactivity, see 
text. 
polyprotein (fig.4). The point in this map to be 
confirmed directly is the assumption that polypep- 
tide B comprises. the sum of the amino acid se- 
quences of Dl and (Y as well as the exact position 
of polypeptide I. 
It is interesting to compare this portion of the 
EMC virus map with the appropriate regions of 
maps of other picornaviruses (fig.4). The 
poliovirus map differs from the EMC map in at 
least two aspects: the former does not appear to 
have leader polypeptides [13- 151 and polypeptide 
VPl, the analogue of cy, seems to occupy the C- 
terminal position of the precursor of poliovirus 
capsid proteins [l&18]. The poliovirus genome 
may also code for an analogue of G, but the latter 
corresponds to a N-terminal portion of polypep- 
tide 3b, a precursor of polypeptide X (fig.4). The 
cleavage map of foot-and-mouth disease virus 
(FMDV), another picornavirus, is in some respects 
intermediate between the EMC virus and 
poliovirus maps. The FMDV polyprotein, like its 
EMC virus counterpart, appears to be initiated 
with leader polypeptides [19], but the FMDV 
analogue of G, if it exists, originates, most pro- 
bably, from polypeptide P52, a precursor encoded 
in the central region of the genome, like in polio 
Volume 154, number 1 FEBS LETTERS April 1983 
EMC VIRUS 
Pre R 
E ‘d 
6 P -- 
POLlOVlRUS 
ia 3b 
30 VP\ 17 5b - -__-- 
VP0 VP3 to x __- 
VP4 VP2 -~ 
FMD” 
P20a P 00 P52 
Pt6 P64 VP! !a P34 ~ ___-- - 
P30 VP3 14 P2Oc __-- 
VP4 VP2 -- 
Fig.4. Cleavage maps of the N-terminal regions of the 
polyproteins of 3 picornaviruses. Data for poliovirus 
were taken from [13-181 and data for FMDV were taken 
from [19,20]. The possibility of alternative cleavage of 
EMC virus polypeptide B into polypeptides e and D2 (as 
well as homologous polypeptides of other picorna- 
viruses) is not illustrated for the sake of simplicity. 
Dotted lines represent hypothetical cleavage products. 
There is no direct evidence that FMDV polypeptides 
P52, P34, and P2Oc are actually C-coterminal. The exact 
position of EMC virus polypeptide I is uncertain. 
(fig.4). Thus, despite a remarkably close similarity 
in the organization of the coding sequences of the 
3 picornaviruses, their detailed cleavage maps ap- 
pear to be different. 
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